3 completed, 3 terminated, 2 unknown, 1 withdrawn. 4 Phase 3, 2 Not applicable, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 2 |
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Chronic Diabetic Foot Ulcers: new trials by email Literature Review of Chronic Diabetic Foot Ulcers trials Research Report on Chronic Diabetic Foot Ulcers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer 5% Bisphosphocin Topical Gel, Placebo Topical Gel, 10% Bisphosphocin Topical Gel - Chronic Diabetic Foot Ulcers | Phase 2 | Terminated | Lakewood-Amedex Inc | 3 | 2022-03-11 | 2024-01-30 |
| Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers ON101 Cream, Vehicle Cream - Chronic Diabetic Foot Ulcers | Phase 3 | Terminated | Oneness Biotech Co., Ltd. | 12 | 2021-07-27 | 2025-03-13 |
| Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) Dual Layer Amniotic Membrane (DLAM). Artacent® - Chronic Diabetic Foot Ulcers | Phase 4 | Unknown | SerenaGroup, Inc. | 124 | 2020-09-01 | 2022-11-04 |
| Beta Adrenergic Antagonist for the Healing of Chronic DFU Timolol, Non biologically active gel - Chronic Diabetic Foot Ulcers, Diabetic Neuropathic Ulcers | Phase 3 | Completed | VA Office of Research and Development | 48 | 2018-07-24 | 2025-05-08 |
| Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers CHAM, Control - Chronic Diabetic Foot Ulcers | Phase 3 | Terminated | Osiris Therapeutics | 108 | 2015-10-01 | 2017-10-06 |
| Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds PrimeStim - Chronic Diabetic Foot Ulcers | Not applicable | Completed | Medical University of Vienna | 24 | 2014-02-01 | 2017-03-31 |
| Shockwave Treatment of Diabetic Foot Ulcer: Step I Extracorporeal Shock Wave - Chronic Diabetic Foot Ulcers | Not applicable | Withdrawn | Technical University of Munich | 2009-08-01 | 2013-03-19 | |
| Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers Soluble beta-glucan (SBG), Placebo comparator - Chronic Diabetic Foot Ulcers | Phase 3 | Completed | Biotec Pharmacon ASA | 122 | 2007-03-01 | 2010-01-26 |
| Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers Extracorporeal Shockwaves - Chronic Diabetic Foot Ulcers | Phase 2 | Unknown | Tissue Regeneration Technologies | 200 | 2006-03-01 | 2006-08-18 |
Foot Ulcer (3) · Diabetes Mellitus (2) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetic Angiopathies (1) · Diabetic Foot (1) · Diabetic Neuropathies (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Leg Ulcer (1) · Metabolic Diseases (1) · Skin Diseases (1) · Skin Ulcer (1) · Vascular Diseases (1)
Foot Diseases (3) · Skin and Connective Tissue Diseases (3) · Leg Ulcer (2) · Nutritional and Metabolic Diseases (2) · Skin Diseases (2) · Skin Ulcer (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Peripheral Nervous System Diseases (1)
Extracorporeal Shockwave Therapy (1) · Hydrogels (1) · Timolol (1)
Biotec Pharmacon ASA (1) · Lakewood-Amedex Inc (1) · Medical University of Vienna (1) · Oneness Biotech Co., Ltd. (1) · Osiris Therapeutics (1) · SerenaGroup, Inc. (1) · Technical University of Munich (1) · Tissue Regeneration Technologies (1) · VA Office of Research and Development (1)
United States (6) · Austria (1) · Germany (1) · Puerto Rico (1) · United Kingdom (1)
Hans Gollwitzer, PD Dr., CCRP (1) · Rivkah R. Isseroff, MD (1) · Sara E. Dahle, DPM MPH (1) · Shyi-Gen Chen (1) · Sumita Paul, MD, MPH (1) · Thomas E Serena, MD,FACS (1) · William Jeffcoate, MD, PhD (1)